C-MER Medical Buys Back 170,000 Shares, Treasury Stock Rises to 24.52 Million

Bulletin Express09-18 17:05

C-MER Medical Holdings Limited (C-MER Medical) reported a minor adjustment to its share capital following an on-market share repurchase conducted on 18 September 2026, according to its latest Next Day Disclosure Return filed with the Hong Kong Stock Exchange.

On 18 September, the company repurchased 170,000 ordinary shares on the Exchange at prices ranging from HKD 0.81 to HKD 0.85 per share, for a total consideration of HKD 0.14 million. The volume-weighted average price was approximately HKD 0.8329 per share.

After the transaction, issued shares outstanding (excluding treasury shares) fell 0.0141 % to 1.208 billion, while treasury shares increased to 24.52 million. The total number of issued shares—including treasury shares—remains unchanged at 1.232 billion.

The buyback was executed under the general mandate approved on 20 May 2026, which permits the repurchase of up to 123.23 million shares. To date, the company has utilised only 0.01 % of this authority, leaving substantial room for further repurchases if deemed appropriate.

In line with Hong Kong listing rules, C-MER Medical is subject to a 30-day moratorium—until 18 October 2026—on issuing new shares or disposing of treasury shares following the latest repurchase.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1147823816?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-18 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147823816","market":"hk","top_or_hot":-1,"title":"C-MER Medical Buys Back 170,000 Shares, Treasury Stock Rises to 24.52 Million","media":"Bulletin Express","content":"<p>C-MER Medical Holdings Limited (C-MER Medical) reported a minor adjustment to its share capital following an on-market share repurchase conducted on 18 September 2026, according to its latest Next Day Disclosure Return filed with the Hong Kong Stock Exchange.</p>\n<p>On 18 September, the company repurchased 170,000 ordinary shares on the Exchange at prices ranging from HKD 0.81 to HKD 0.85 per share, for a total consideration of HKD 0.14 million. The volume-weighted average price was approximately HKD 0.8329 per share.</p>\n<p>After the transaction, issued shares outstanding (excluding treasury shares) fell 0.0141 % to 1.208 billion, while treasury shares increased to 24.52 million. The total number of issued shares—including treasury shares—remains unchanged at 1.232 billion.</p>\n<p>The buyback was executed under the general mandate approved on 20 May 2026, which permits the repurchase of up to 123.23 million shares. To date, the company has utilised only 0.01 % of this authority, leaving substantial room for further repurchases if deemed appropriate.</p>\n<p>In line with Hong Kong listing rules, C-MER Medical is subject to a 30-day moratorium—until 18 October 2026—on issuing new shares or disposing of treasury shares following the latest repurchase.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER Medical Buys Back 170,000 Shares, Treasury Stock Rises to 24.52 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER Medical Buys Back 170,000 Shares, Treasury Stock Rises to 24.52 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-18 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>C-MER Medical Holdings Limited (C-MER Medical) reported a minor adjustment to its share capital following an on-market share repurchase conducted on 18 September 2026, according to its latest Next Day Disclosure Return filed with the Hong Kong Stock Exchange.</p>\n<p>On 18 September, the company repurchased 170,000 ordinary shares on the Exchange at prices ranging from HKD 0.81 to HKD 0.85 per share, for a total consideration of HKD 0.14 million. The volume-weighted average price was approximately HKD 0.8329 per share.</p>\n<p>After the transaction, issued shares outstanding (excluding treasury shares) fell 0.0141 % to 1.208 billion, while treasury shares increased to 24.52 million. The total number of issued shares—including treasury shares—remains unchanged at 1.232 billion.</p>\n<p>The buyback was executed under the general mandate approved on 20 May 2026, which permits the repurchase of up to 123.23 million shares. To date, the company has utilised only 0.01 % of this authority, leaving substantial room for further repurchases if deemed appropriate.</p>\n<p>In line with Hong Kong listing rules, C-MER Medical is subject to a 30-day moratorium—until 18 October 2026—on issuing new shares or disposing of treasury shares following the latest repurchase.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03309","symbol_name":"希玛医疗","start_time":0,"source_url":"","article_id":"1147823816","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147823816","pubTimestamp":1789722333,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"C-MER Medical Holdings Limited (C-MER Medical) reported a minor adjustment to its share capital following an on-market share repurchase conducted on 18 September 2026, according to its latest Next...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03309":"希玛医疗"},"translate_title":"C-MER Medical回购17万股，库存股增至2452万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"C-MER Medical Holdings Limited (C-MER Medical) reported a minor adjustment to its share capital following an on-market share repurchase conducted on 18 September 2026, according to its latest Next Day Disclosure Return filed with the Hong Kong Stock Exchange.\nOn 18 September, the company repurchased 170,000 ordinary shares on the Exchange at prices ranging from HKD 0.81 to HKD 0.85 per share, for a total consideration of HKD 0.14 million. The volume-weighted average price was approximately HKD 0.8329 per share.\nAfter the transaction, issued shares outstanding (excluding treasury shares) fell 0.0141 % to 1.208 billion, while treasury shares increased to 24.52 million. The total number of issued shares—including treasury shares—remains unchanged at 1.232 billion.\nThe buyback was executed under the general mandate approved on 20 May 2026, which permits the repurchase of up to 123.23 million shares. To date, the company has utilised only 0.01 % of this authority, leaving substantial room for further repurchases if deemed appropriate.\nIn line with Hong Kong listing rules, C-MER Medical is subject to a 30-day moratorium—until 18 October 2026—on issuing new shares or disposing of treasury shares following the latest repurchase.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1147823816","isCrawlerRequest":true}